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Abstract
Objective—Chronic pain affects both psychological and physical functioning, and is responsible 
for more than $60 billion in lost productivity annually in the United States. Although previous 
studies have demonstrated racial disparities in opioid treatment, there is little evidence regarding 
disparities in treatment of chronic non-cancer pain (CNCP) and the role of physician specialty.
Design—A retrospective cohort study.
Setting—We analyzed North Carolina Medicaid claims data, from July 1, 2009 to May 31, 2010, 
to examine disparities by different provider specialties in beneficiaries dispensed prescriptions for 
opioids.
Subjects—The population included White and Black North Carolina Medicaid beneficiaries with 
CNCP (n=75,458).
Methods—We used bivariate statistics and logistic regression analysis to examine race-based 
discrepancies in opioid prescribing by physician specialty.
Results—Compared to White beneficiaries with CNCP (n=49,197), Black beneficiaries 
(n=26,261) were less likely [OR 0.91 (CI: 0.88–0.94)] to fill an opioid prescription. Our 
hypothesis was partially supported: we found that race-based differences in beneficiaries 
dispensed opioid prescriptions were more prominent in certain specialties. In particular, these 
differences were most salient among patients of specialists in obstetrics and gynecology [OR 0.78 
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(CI: 0.67–0.89)] and internal medicine [OR 0.86 (CI: 0.79–0.92)], as well as general practitioners/
family medicine physicians [OR 0.91 (CI: 0.85–0.97)].
Conclusions—Our findings suggest that, in our study population, Black beneficiaries with 
CNCP are less likely than Whites to fill prescriptions for opioid analgesics as a function of their 
provider’s specialty. Although race-based differences in patients filling opioid prescriptions have 
been noted in previous studies, this is the first study that clearly demonstrates these disparities by 
provider specialty.
Chronic non-cancer pain (CNCP) affects both psychological and physical functioning,1 and 
is responsible for more than $60 billion in lost productivity annually in the United States.2 
Despite limited evidence for the chronic use of opioid analgesics in CNCP, opioid 
prescribing has increased substantially in recent decades and professional organizations have 
commissioned guidelines for the use of opioids for patients with CNCP.3
Multiple studies have shown race- and ethnicity-based disparities in opioid prescribing 
practices.4–8 Although the reasons underlying these discrepancies remain ill-defined,8 
current literature documents that Blacks receive fewer prescriptions than do non-Hispanic 
Whites in response to complaints of chronic non-cancer pain.8–12 For over a decade, racial 
and ethnic minorities have been shown to be at elevated risk for oligoanalgesia, defined as 
the underuse of analgesics in response to valid indications of pain.1,13 This persists despite 
the World Health Organization specifying access to appropriate palliative care as a 
fundamental human right.11,14 It increasingly appears that providers’ decision-making 
concerning prescriptions for analgesics is affected by their patients’ race and ethnicity, even 
when controlling for their patients’ income, type of insurance, and access to care,15 as well 
as their stated preferences, reported level of pain, and other clinical indicators.4,5
Several studies have indicated that providers are more likely to underestimate pain reported 
by minority patients than by White patients, and are less likely to document their minority 
patients’ pain scores. These findings, which are remarkably robust across a range of 
populations and settings suggest that providers may be partially responsible for issues 
related to oligoanalgesia among minority patients.10,16 Providers’ CNCP treatment decisions 
are particularly challenging, as concerns about overprescribing of opioids persist,17,18 and 
clinical findings upon which treatment decisions are based are ambiguous,19 depending 
largely on patients’ self-reports of the intensity and source of their pain8,19 In uncertain 
conditions, the race and ethnicity of providers’ patients may play a role in their decisions,4 
particularly if there are race-related cultural issues that may impede communication within 
race-discordant patient-provider relationships.20,21 There may also be institutional barriers 
to minority patients’ access to palliative medications; one study found that minority patients’ 
access to pain specialists may be lower than that of White patients.22 Further, pharmacies 
serving minority neighborhoods may be less likely to stock opioid analgesics than those 
situated in majority communities.23 If so, minority patients may experience more difficulty 
than White patients when they seek to fill prescriptions for these medications. Finally, 
minority patients may be particularly constrained from seeking treatment by lack of 
insurance.24
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Little is known about how specialized training may contribute to racial disparities in 
analgesic prescribing for CNCP patients, although it is generally believed that physician 
education related to the management of chronic pain is inadequate.25 One study reported 
that physicians’ status as either a resident or attending was not related to their opioid 
prescribing behaviors among black patients,26 although an association has been reported 
between specialty pain management training and providers’ willingness to prescribe 
opioids.27 The observation that stereotype-based actions predominate in situations of 
uncertainty implies that specialists would be less likely to rely on such stereotypes when 
prescribing opioid pain medications. It is also possible that specialists, who tend to 
congregate in urban environments, may be less affected by racial stereotypes than general 
practitioners, who are more evenly distributed across both urban and rural areas.28
The purpose of this study was to examine differences across providers specialties in 
prescriptions filled by White and Black Medicaid beneficiaries with CNCP. We 
hypothesized that patients patients treated by specialists would be less likely to experience 
race-based discrimination, as manifested in filled opioid prescriptions, than patients cared 
for by general practitioners.
Methods
This study was approved by the University of North Carolina Institutional Review Board.
Data
We utilized a dataset comprising North Carolina Medicaid claims from July 1, 2009 to May 
31, 2010. Medicaid beneficiaries age 18–64 with CNCP were identified. Beneficiaries were 
excluded from the dataset if they had both a cancer and a chronic pain diagnosis. 
Beneficiaries were also excluded from the dataset if they indicated that their primary racial 
or ethnic affiliation was anything other than White or Black. The percentage of Hispanics/
Latinos (8.5%) and others (7.1%) in the sample was insufficient to permit analyses of CNCP 
opioid prescriptions among provider specialties.
Measures
Medicaid beneficiaries were categorized as having CNCP if they had an ICD-9 diagnosis 
code at any point during the study period for any of the following diagnoses: chronic pain 
syndrome, headaches (e.g., migraine, tension, or chronic), back pain, neck pain, spinal cord 
injury, arthritic disease (including lupus and fibromyalgia), sickle cell anemia, and burns. 
The specific ICD-9 codes associated with these diagnoses are available upon request. Note 
that a given patient could have been classified as having multiple CNCP diagnoses.
We defined opioid analgesic receipt as a Medicaid prescription claim for a drug in 
therapeutic class code 40, based on the NDC Directory of therapeutic drug classes.29 For the 
purpose of this study, we only specified CNCP beneficiaries as receiving opioid analgesics if 
they filled the prescriptions on or after the date of their physician’s diagnosis, as specified in 
their claims record. We utilized this strategy to increase the likelihood that the opioid 
prescription would be directly related to the beneficiaries’ CNCP diagnosis.
Ringwalt et al. Page 3













We categorized providers based on their self-report of their specialty to Medicaid as: ear, 
nose, and throat (ENT); dentistry; general practitioners and family medicine (GP/FM); 
internal medicine; emergency medicine; orthopedics; or obstetrics and gynecology (OB/
GYN). We chose these specialties as they are those most likely to care for beneficiaries with 
CNCP. No providers were excluded; those reporting any other specialty (e.g., cardiology) 
are included in an “other” category.
Beneficiaries reported their own race/ethnicity to Medicaid as White, Black, Hispanic/
Latino, or other. As mentioned earlier, we excluded all beneficiaries from our data except 
those identified as White or Black. Other demographic variables available in the dataset 
were sex and age.
Missing data
During the process of preparing the analysis dataset for this study, we found that 1,584,757 
(56.8%) of 2,789,823 prescriptions for beneficiaries meeting inclusion criteria lacked 
provider specialty information. The North Carolina Medicaid program does not require 
providers to enter their specialty in prescription claim reimbursement forms. We examined 
whether the presence of these data was associated with any of their patients’ demographic 
characteristics and primary diagnoses due to the concern that missing data may bias our 
analysis of the relationship between beneficiaries’ race and providers’ specialty (see Table 
1). In addition, we examined the relationship between specialty missing status, any 
prescriptions (N= 2,789,823), and any opioid prescriptions (N=352,127). All comparisons 
made in this dataset were statistically significant. We therefore focused on whether any 
observed differences were clinically meaningful. In regards to race, records of Black 
beneficiaries were about 1.5 percentage points more likely to have missing data concerning 
provider specialty for any prescription than were records of White beneficiaries. However, 
that difference attenuated to 0.5 percentage points when we examined differences by race for 
any opioid prescription.
Differences found by sex were also modest (less than 2 percentage points). However, we did 
find a clear trajectory across age groups – younger beneficiaries were less likely than older 
beneficiaries to have missing provider specialty data – although the difference in the percent 
of these data between the youngest and highest age groups was greater for all prescriptions 
(6.6 percentage points) than for all opioid prescriptions (4.8 percentage points). Our 
examination of the relationship between the presence or absence of specialty information 
and beneficiaries’ chronic pain-related diagnoses revealed similarly small differences in 
regards to whether or not data for this variable were missing.
Given the low magnitude of the differences displayed by beneficiaries’ demographic 
characteristics and chronic pain diagnoses, we elected to address missing data through 
complete case analysis by limiting our dataset to claims with no missing data (N= 
1,205,066). This decision was based on the concern that any imputation procedures would 
risk generating more bias than that caused by the missing data themselves, as we could not 
be certain that missing values could be entirely explained with available data. We also had 
adequate power to address the study’s research questions despite excluding those 
observations.
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We began by describing our sample, restricted to White and Black beneficiaries with CNCP 
diagnoses. Bivariate differences in prescribing practices by specialty across patient race (i.e., 
White or Black) were then examined. All chi-square statistics were found to be statistically 
significant. Therefore, we did not report conventional levels of significance, but focused 
instead on clinical significance.
For multivariate analyses, we restricted the sample to beneficiaries who filled at least one 
prescription of any type, regardless of whether it was for an analgesic, the day of, or any day 
following, the visit in which they received a CNCP diagnosis code. Maximum likelihood 
logistic regression models were used to examine the relationship between beneficiaries’ race 
and receipt of an opioid prescription, while controlling for age, sex, and their CNCP 
diagnoses. Because we were most interested in differences by specialty, we performed 
logistic regression that predicted the odds of filling an opioid prescription received from 
each specialty. We adjusted the standard errors for within-person similarities across multiple 
prescriptions (e.g., an individual is likely to receive care from the same specialist) using a 
sandwich variance estimator. We calculated standard errors using the Huber-White robust 
variance method30 after subtracting the number of covariates from the number of 
observations. Sandwich variance estimators, which are used with generalized estimating 
equations, provide reliable estimates of covariance matrices even in the absence of 
parametric models.31 All analyses were performed in STATA 13.0 (College Station, Texas).
Results
Sample description
Data examined for the 12-month period beginning July 1, 2009 included a total of 1.29 
million covered adults between the ages of 18 and 64, and 1.08 million who self-reported as 
either White or Black. Our analysis dataset comprised 75,458 (6.97%) of White and Black 
beneficiaries who had a diagnosis code for CNCP associated with visits during the 12-month 
study period. Altogether, 48,122 (4.5%) beneficiaries received both a CNCP diagnosis and at 
least one prescription for an opioid analgesic, filled by their pharmacist either on the same 
day of, or any day subsequent to, the day their diagnosis was recorded. Of these, 33,256 
white beneficiaries and 14,866 Black beneficiaries filled a prescription.
As indicated in Table 2, among White and Black beneficiaries with CNCP diagnoses, a 
majority were female (69.6%) and White (65.2%). Beneficiaries were approximately evenly 
distributed across the age groups specified. Almost two-thirds (63.8%) of beneficiaries had 
filled at least one opioid prescription during the year. There were more White beneficiaries 
in the group that filled an opioid prescription (69.1%) than in the group that did not (58.3%). 
Although age was evenly distributed among White and Black CNCP beneficiaries who filled 
at least one opioid prescription, those who did not receive an opioid were more likely to be 
older. Table 2, which also includes information about the distribution of key clusters of 
diagnoses related to chronic pain, reveals that beneficiaries with chronic pain syndrome and 
back pain, relative to the other pain-related diagnoses examined, were particularly likely to 
fill a prescription for an opioid.
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All analyses testing the study’s hypothesis are based on the 68,175 White and Black 
beneficiaries with CNCP who filled at least one prescription of any type, regardless of 
whether it was an analgesic, on the day of, or any day following, the visit in which they 
received a CNCP diagnosis code. Of all prescriptions filled by White and Black beneficiaries 
with CNCP, 12.6% were for opioids. Table 3 displays the distribution, by race, of provider 
specialties prescribing these opioid analgesics as a function of all the prescriptions the 
providers in each specialty wrote. Every specialty, with the exception of ENT physicians, 
wrote a greater proportion of opioid prescriptions for Whites than for Blacks.
The results of our multivariable analyses, which are displayed in Table 4, confirm the results 
of the bivariate analyses presented above. In these analyses we examined the relationship 
between CNCP beneficiaries’ race and the odds of receiving an opioid prescription for each 
physician specialty, controlling for age, gender, and diagnosis. Overall, the odds of receiving 
an opioid prescription was 9% lower for Black CNCP beneficiaries than for White CNCP 
beneficiaries [OR 0.91 (95% CI: 0.88 – 0.94)]. These disparities were particularly salient at 
the provider specialty level for OB/GYN [OR 0.78 (95% CI: 0.67 – 0.89)], internal medicine 
[OR 0.86(95% CI: 0.79 – 0.92)], and general practitioners/family medicine [OR 0.91 (95% 
CI: 0.85 – 0.97)].
Discussion
In this study of the North Carolina Medicaid population with a diagnosis of chronic non-
cancer pain (CNCP), we found that, overall, Blacks were 9% less likely than Whites to fill 
an opioid prescription, when controlling for age, sex, and chronic pain diagnosis. OB/GYN, 
internal medicine, and general practice/family medicine specialties were primary 
contributors to this disparity; relative to White CNCP beneficiaries, Black CNCP 
beneficiaries were 22%, 14%, and 9% less likely to fill opioid prescriptions, respectively. 
Much of the previous research on race differentials in opioid prescribing practices has 
focused on emergency department encounters.7,32 Our study adds to this literature by 
providing results for multiple specialties across a variety of care sites and CNCP diagnoses. 
Whereas chronic opioid therapy is not generally recommended as a first-line treatment for 
CNCP, it is likely that the differences observed are multifactorial, encompassing providers’ 
responses to their individual beneficiaries, patient-related health care accessibility issues , 
and patient-driven demand.
The data utilized in this study do not shed light on the problems that can result from biased 
prescribing data, e.g. the over- or under-medication of White or Black Medicaid 
beneficiaries. A number of studies raise the concern, however, that Blacks are at elevated 
risk of oligoanalgesia and that their providers may systematically underestimate the chronic 
pain they experience.10,33,34 Further, across multiple settings, clinicians are less likely to 
assess and treat their Black patients’ pain than their White patients' pain.34 The authors of an 
IOM report19 suggest that these disparities in care may be attributed to racial bias and 
stereotypes, or to elevated rates of uncertainty as to how to respond to minority patients. Our 
findings provide further understanding to this discussion: we have not only replicated earlier 
findings regarding differential race-based opioid dispensing, but have also revealed the 
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presence of differences in race-based dispensing by provider specialty. Given this, we 
believe our findings represent a cause for concern on the part of providers who treat patients 
with CNCP. We also note that the odds ratios we reported for all specialties considered in 
aggregate, and for general practitioners in particular, were both modest (.91) in magnitude. 
However, these odds rations indicate almost a 10% reduced likelihood of receiving 
treatment, which represents a clinically significant effect.
Another factor that may explain lower rates of opioid prescriptions among Black 
beneficiaries is inadequate access to care. The effective management of chronic opioid 
therapy requires ongoing and regular care to ensure appropriate use.35 Inadequate access 
may lead to physicians’ inability to properly manage continuous opioid therapy, leading to 
reduced rates of prescribing.
Finally, patients’ response to pain and their communication about pain may influence 
prescribing practices. Studies have shown that Blacks may report a higher level of pain than 
Whites in regards to several conditions, including arthritis, headache, abdominal discomfort, 
and musculoskeletal conditions.36,37 Several investigators have speculated that Blacks have a 
higher level of sensitivity to pain than Whites.38 However, Black patients also tend to 
understand less than Whites about their medical conditions, communicate less effectively 
with their providers, trust their providers less, and rely more on self-management strategies 
for pain.8,9 These differences in knowledge, communication, trust, and self-management 
strategies may at least partially account for the racial disparities seen in both the present and 
preceding studies on opioid prescribing and race. Study data only captured prescriptions that 
were filled by Medicaid recipients, not all prescriptions that were written. Patients who 
chose not to fill opioid prescriptions would therefore be missing from the data, resulting in 
the inaccurate assumption of differential prescribing.
We only partially validated the study hypothesis that we would find a greater racial disparity 
in opioid prescribing behaviors for general practitioners than for all specialists, as both 
OB/GYN practitioners and internal medicine specialists were less likely than GPs to 
prescribe opioids to their Black patients with CNCP. We are uncertain as to why this is the 
case, and are reluctant to speculate because of the novelty of our findings. We suggest that 
future studies should attempt to replicate our findings and then examine the effects of these 
disparities, addressing whether White patients are over-treated with opioids or Black patients 
are under-treated.
We acknowledge two limitations to our study. First, our study targeted Medicaid 
beneficiaries, who are twice as likely as those in the general population to fill an opioid 
prescription.39 Thus our findings may not be applicable to providers of CNCP patients in 
non-Medicaid populations. There is one particular advantage to our focus on Medicaid 
beneficiaries: the program’s eligibility criteria automatically control for socio-economic 
status, which may otherwise confound observed relationships between race, health practices, 
and outcomes.
Second, we are aware of the problems caused by missing specialty information in our 
dataset, particularly the potential for bias if these data were differentially associated either 
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with physicians’ specialty or with patients’ opioid prescriptions. However, our examination 
of the differences indicated few concerns about bias based on the data available to us. This is 
further supported by our exclusive reliance on objective administrative records.
In conclusion, our findings suggest that access to dispensed opioid analgesic prescriptions 
may be somewhat limited for Black beneficiaries with CNCP in our Medicaid sample, 
depending on their provider type. This issue is worthy of attention by the medical 
community, and particularly by groups of providers who represent obstetricians and 
gynecologists, internal medicine specialists, and family medicine practitioners. We strongly 
believe that all CNCP patients have a right to accessible and effective pain management,14 
informed by evidence-based guidelines for the appropriate, judicious use of chronic opioid 
therapy in CNCP.3 Prompt action is needed on many fronts. These include the promotion of 
more accurate assessments of pain levels, the enhancement of provider training related to 
cultural competence and the recognition and reduction of racial stereotyping, and the 
education of patients suffering from CNCP as to how to enhance their communications with 
their providers about optimal strategies to manage their pain.
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Table 3
Percent of prescriptions for opioid analgesics, by specialty and race, filled by Medicaid beneficiaries
Prescriptions filled by White beneficiaries Prescriptions filled by Black beneficiaries
Total N % Opioids Total N % Opioids
All specialties*** 881,203 13.2 323,863 11.2
ENT physicians 3,499 11.0 1,209 11.3
Dentists** 18,506 27.2 7,997 25.1
GP/FM*** 289,039 9.3 83,887 7.9
Internal medicine*** 158,097 9.0 82,871 7.6
Emergency medicine 57,563 23.3 24,975 22.2
Orthopedists* 19,362 42.4 7,179 39.4
OB/GYN*** 34,527 11.0 12,917 7.8
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Table 4
Results of multivariable logistic regression models predicting the odds of filling an opioid prescription for 
Black relative to White CNCP Medicaid beneficiaries
OR CI
Specialties
 Overall*** 0.91 [0.88 −0.94]
 ENT physicians 1.11 [0.79 −1.58]
 Dentists 0.94 [0.88 −1.02]
 GP/FM** 0.91 [0.85 −0.97]
 Internal medicine*** 0.86 [0.79 −0.92]
 Emergency medicine 0.99 [0.93 −1.05]
 Orthopedics 0.91 [0.82 −1.03]
 OB/GYN*** 0.78 [0.67 −0.89]







Note: CNCP = chronic non-cancer pain; all models controlled for age, sex, and specific CNCP diagnoses
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